Alnylam Pharmaceuticals
ALNY
#567
Rank
HK$287.49 B
Marketcap
HK$2,230
Share price
-2.26%
Change (1 day)
73.88%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company